Hodgkin's disease in childhood: A review

Journal of Pediatric Hematology/Oncology

Volumn 19, Issue 6, 1997, Pages 502-509

  Raney, R Beverly ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; LOMUSTINE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE SULFATE;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CARDIOTOXICITY; CHILD; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; DRUG INDUCED DISEASE; FEMALE; HODGKIN DISEASE; HUMAN; LAPAROTOMY; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SECOND CANCER; SPLENECTOMY;

CHILD; HODGKIN DISEASE; HUMANS;

EID: 0031405979     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199711000-00003     Document Type: Review

References (64)

1. Cleary SF, Link MP, Donaldson SS. Hodgkin's disease in the very young. Int J Rad Oncol Biol Phys 1994;28:77-83.
2. Kung FH. Hodgkin's disease in children 4 years of age or younger. Cancer 1991;67:1428-30.
3. Young JL Jr., Ries LG, Silverberg E, et al. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 1986;58:598-602.
4. Macfarlane GJ, Evstifeeva T, Boyle P, et al. International patterns in the occurrence of Hodgkin's disease in children and young adult males. Int J Cancer 1995;61:165-9.
5. Armstrong AA, Alexander FE, Paes RP, et al. Short communication: association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol 1993;142:1683-8.
6. Jarrett R, Onions D. Viruses and Hodgkin's disease. Leukemia 1992;6 (Suppl. 1):14-7.
7. Khan G, Coates PJ. The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease. J Pathol 1994;174:141-9.
8. Mack TM, Cozen W, Shibata DK, et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 1995;332:413-8.
9. Diehl V, Tesch H. Hodgkin's disease-Environmental or genetic? N Engl J Med 1995;332:461-2.
10. Doehner H, Bloomfield CD, Frizzera G, et al. Recurring chromosome abnormalities in Hodgkin's disease. Genes Chromosomes Cancer 1992;5:392-8.
11. Bhagat SKM, Medeiros J, Weiss LM, et al. bcl-2 expression in Hodgkin's disease. Am J Clin Pathol 1993;99:604-8.
12. Hanna SL, Fletcher BD, Boulden TF, et al. MR imaging of infradiaphragmatic lymphadenopathy in children and adolescents with Hodgkin disease: comparison with lymphography and CT. J Magn Reson Imaging 1993;3:461-70.
13. Schellong G, Waubke-Landwehr A-K, et al. Prediction of splenic involvement in children with Hodgkin's disease: significance of clinical and intraoperative findings: a retrospective statistical analysis of 154 patients in the German Therapy Study DAL-HD-78. Cancer 1986;57:2049-56.
14. Hoekstra HJ, Tamminga RYJ, Timens W. Partial splenectomy in children: an alternative for splenectomy in the pathological staging of Hodgkin's disease. Ann Surg Oncol 1994;1:480-6.
15. Breuer CK, Tarbell NJ, Mauch PM, et al. The importance of staging laparotomy in pediatric Hodgkin's disease. J Pediatr Surg 1994;29:1085-9.
16. Hays DM, Fryer CH, Pringle KC, et al. An evaluation of abdominal staging procedures performed in pediatric patients with advanced Hodgkin's disease: a report from the Childrens Cancer Study Group. J Pediatr Surg 1992;27:1175-80.
17. Mendenhall NP, Cantor AB, Williams JL, et al. With modern imaging techniques, is staging laparotomy necessary in pediatric Hodgkin's disease? A Pediatric Oncology Goup Study. J Clin Oncol 1993;11:2218-25.
18. Donaldson SS. Making choices in the staging of children with Hodgkin's disease. Med Pediatr Oncol 1991;19:211-3.
19. Garden AS, Woo SY, Fuller LM, et al. Results of a changing treatment philosophy for children with Stage I Hodgkin's disease: a 35-year experience. Med Pediatr Oncol 1991;19:214-20.
20. Gehan EA, Sullivan MP, Fuller LM, et al. The Intergroup Hodgkin's disease in children: a study of Stages I and II. Cancer 1990; 65:1429-37.
21. Schellong G, Brämswig JH, Hörnig-Franz I, et al. Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA: results in 356 patients of the German/Austrian Pediatric Study Group. Ann Oncol 1994;5 (Suppl 2):S113-5.
22. Yaniv I, Saab A, Cohen IJ, et al. Hodgkin's disease in children: reduced tailored chemotherapy for Stage I-II disease. J Pediatr Hematol Oncol 1996;18:76-80.
23. Donaldson SS, Link MP. Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol 1987;5:742-9.
24. Hunger SP, Link MP, Donaldson SS. ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience. J Clin Oncol 1994;12:2160-6.
25. Jenkin D, Doyle J, Berry M, et al. Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy late results and toxicity. Med Pediatr Oncol 1990;18:265-72.
26. Maity A, Goldwein JW, Lange B, et al. Comparison of high-dose and low-dose radiation with and without chemotherapy for children with Hodgkin's disease: an analysis of the experience at the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania. J Clin Oncol 1992;10:929-35.
27. Hudson MM, Greenwald C, Thompson E, et al. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 1993;11:100-8.
28. Schellong G, Brämswig JH, Hörnig-Franz I. Treatment of children with Hodgkin's disease-Results of the German Pediatric Oncology Group. Ann Oncol 1992;3 (Suppl. 4):S73-6.
29. Oberlin O, Leverger G, Pacquement H, et al. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology. J Clin Oncol 1992;10:1602-8.
30. Vecchi V, Pileri S, Burnelli R, et al. Treatment of pediatric Hodgkin's disease tailored to stage, mediastinal mass, and age. Cancer 1993;72:2049-57.
31. Fryer CJ, Hutchinson RJ, Krailo M, et al. Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Childrens Cancer Study Group. J Clin Oncol 1990; 8:1971-80.
32. Bader SB, Weinstein H, Mauch P, et al. Pediatric Stage IV Hodgkin's disease. Cancer 1993;72:249-55.
33. Ekert H, Waters KD, Smith PJ, et al. Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease. J Clin Oncol 1988;6:1845-50.
34. Lobo-Sanahuja F, Garcia I, Barrantes JC, et al. Pediatric Hodgkin's disease in Costa Rica: twelve years' experience of primary treatment by chemotherapy alone, without staging laparotomy. Med Pediatr Oncol 1994;22:398-403.
35. Behrendt H, Brinkhuis M, van Leeuwen EF. Treatment of childhood Hodgkin's disease with ABVD without radiotherapy. Med Pediatr Oncol 1996;26:244-8.
36. Baez F, Ocampo E, Conter V, et al. Treatment of childhood Hodgkin's disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua. Ann Oncol 1997;8:247-50.
37. Burns LJ, Daniels KA, McGlave PB, et al. Autologous stem cell transplantation for refractory and relapsed Hodgkin's disease: factors predictive of prolonged survival. Bone Marrow Transplant 1995;16:13-8.
38. Kaldor JM, Day NE, Clarke EA, et al. Leukemia following Hodgkin's disease. N Engl J Med 1990;322:7-13.
39. Tura S, Fiacchini TM, Zinzani PL, et al. Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J Clin Oncol 1993;11:925-30.
40. Boivin J-F, Hutchison GB, Zauber AG, et al. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 1995;87:732-41.
41. Dietrich P-Y, Henry-Amar M, Cosset J-M, et al. Second primary cancers in patients continously disease-free from Hodgkin's disease: a protective role for the spleen? Blood 1994;84:1209-15.
42. Boice JD Jr., Travis LB. Body wars: effect of friendly fire (cancer therapy). J Natl Cancer Inst 1995;87:705-6.
43. Meadows AT, Obringer AC, Marrero O, et al. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors. Med Pediatr Oncol 1989; 17:477-84.
44. Beaty O III, Hudson MM, Greenwald C, et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 1995;13:603-9.
45. Jenkin D, Greenberg M, Fitzgerald A. Second malignant tumours in childhood Hodgkin's disease. Med Pediatr Oncol 1996;26:373-9.
46. Salloum E, Doria R, Schubert W, et al. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol 1996; 14:2435-43.
47. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993;85:25-31.
48. Yahalom J, Petrek JA, Biddinger PW, et al. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 1992;10:1674-81.
49. Silber JH, Littman PS, Meadows AT. Stature loss following skeletal irradiation for childhood cancer. J Clin Oncol 1990;8:304-12.
50. Willman KY, Cox RS, Donaldson SS. Radiation induced height impairment in pediatric Hodgkin's disease. Int J Rad Oncol Biol Phys 1994;28:85-92.
51. Clark ST, Radford JA, Crowther D, et al. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. J Clin Oncol 1995;13:134-9.
52. Dhabhar BN, Malhorta H, Joseph R, et al. Gonadal function in prepubertal boys following treatment for Hodgkin's disease. J Pediatr Hematol Oncol 1993;15:306-10.
53. Shafford EA, Kingston JE, Malpas JS, et al. Testicular function following the treatment of Hodgkin's disease in childhood. Br J Cancer 1993;68:1199-204.
54. Aisner J, Wiernik PH, Pearl P. Pregnancy outcome in patients treated for Hodgkin's disease. J Clin Oncol 1993;11:507-12.
55. Lipshultz SE, Sallan SE. Cardiovascular abnormalities in long-term survivors of childhood malignancy. J Clin Oncol 1993; 11:1199-203.
56. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993;11:1208-15.
57. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993;270:1949-55.
58. Valagussa P, Santoro A, Bonadonna G. Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease. Ann Oncol 1992;3 (Suppl. 4):S111-5.
59. Horning SJ, Adhikari A, Rizk N, et al. Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study. J Clin Oncol 1994;12:297-305.
60. Longo DL. The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease. Cancer Invest 1996;14:353-60.
61. Prosnitz LR, Wu JJ, Yahalom J. The case for adjuvant radiation therapy in advanced Hodgkin's disease. Cancer Invest 1996;14:361-70.
62. Maity A, Goldwein JW, Lange B, et al. Mediastinal masses in children with Hodgkin's disease. Cancer 1992;69:2755-60.
63. James ND, Kingston JE, Plowman PN, et al. Outcome of children with resistant and relapsed Hodgkin's disease. Br J Cancer 1992;66:1155-8.
64. Hudson MM. Treatment of childhood Hodgkin's disease with chemotherapy alone. Ann Oncol 1997;8:215-6.